Search

everythinglearnresearchcommunity

for

Search:↓

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Oral baricitinib is effective and safe for treating alopecia areata.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

Secukinumab effectively treated a difficult case of folliculitis decalvans.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

New treatments for lupus show promise, but more research is needed, especially for children.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Dupilumab for eczema may cause hair loss.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

CGF therapy may help hair regrowth and improve scars in DLE patients.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

IVIG and dupilumab effectively improved symptoms in a child with Netherton syndrome.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.